Advertisement
Home Tags Prescription Drugs

Tag: Prescription Drugs

When pharmacies close

Heart Patients at Risk When Pharmacies Close

Study shows link between pharmacy closures and medication noncompliance among patients with CVD
Fournier gangrene is a safety concern for adults with diabetes receiving treatment with sodium-glucose cotransporter-2 inhibitors

Fournier Gangrene Is Safety Concern With SGLT2 Inhibitors

FDA identified 55 cases of FG in patients on SGLT2 inhibitors from March 2013 through January 2019
For patients with psoriasis treated with systemic medications

Infection Risk Lower With Certain Psoriasis Treatments

Risk for serious infection reduced for new users of apremilast, etanercept, ustekinumab versus methotrexate
For internal medicine residents

Prior Training Increases Internists’ Knowledge of PrEP for HIV

IM residents with training report more frequent prescribing, higher comfort level in educating patients
Isradipine does not appear to slow progression of disability in patients with de novo Parkinson disease

AAN: Isradipine Offers No Benefit in Parkinson Disease

No significant treatment effect seen in UPDRS Part I to III score measured in the ON state
For patients with aquaporin-4-immunoglobulin G-positive neuromyelitis optica spectrum disorder

AAN: Eculizumab Reduces Risk for Relapse in Neuromyelitis Optica

But no significant between-group difference noted in measures of disability progression
The use of alteplase between 4.5 and 9.0 hours after stroke onset results in a higher number of patients with no or minor neurological deficits

Alteplase Seems Beneficial at 4.5 to 9.0 Hours After Stroke

Trial terminated because of loss of equipoise after publication of positive results from previous trial
In 2015 to 2016

In 2015 to 2016, 45.8 Percent of U.S. Population Used Rx Drugs

Prescription drug use increased with age, reaching 85.0 percent for those aged 60 years and older
In response to public demands for action to control drug costs

Prices Will Soon Be Included in TV Drug Ads

Regulations will require companies to disclose prices of meds costing more than $35 for a month's supply
The average price for single-source brand-name drugs is higher in the United States than in other countries

External Reference Pricing Could Cut Drug Costs in U.S.

Prices averaged 3.2 to 4.1 times higher in U.S.; differential varied from 1.3 to 70.1 for individual drugs